Nakae covers the Healthcare sector, focusing on stocks such as Ibio, Pharma Mar SA, and Alto Neuroscience, Inc.. According to TipRanks, Nakae has an average return of 1.9% and a 37.60% success rate on recommended stocks.
Pharma Mar SA has an analyst consensus of Moderate Buy, with a price target consensus of €110.41.
The company has a one-year high of €105.20 and a one-year low of €64.00. Currently, Pharma Mar SA has an average volume of 86.56K.
Based on the recent corporate insider activity of 17 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PHMMF in relation to earlier this year.
